United States
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • @
  • Artificial intelligence
  • Arts and design
  • Books
  • Business
  • Celebrities
  • Chicago
  • Computing
  • Dallas
  • Economy
  • Entertainment
  • Entrepreneurship
  • Environment
  • Fitness
  • Fort Worth
  • Gadgets
  • Genetics
  • Golf
  • Health
  • Health care
  • Houston
  • Internet
  • Jacksonville
  • Jobs
  • Los Angeles
  • Markets
  • Medication
  • Mental health
  • MLB
  • Mobile
  • Movies
  • Music
  • NASCAR
  • NBA
  • NCAA Basketball
  • NCAA Football
  • New York
  • News
  • NFL
  • NHL
  • Nutrition
  • Personal finance
  • Philadelphia
  • Phoenix
  • Physics
  • San Antonio
  • San Diego
  • Science
  • Soccer
  • Space
  • Sports
  • Technology
  • Tennis
  • TV
  • United States
  • US
  • Virtual reality
  • Wildlife
  • WNBA
  • World
United States
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • CH
    • DK
    • PL
    • UK
  • News
  • US
  • World
  • Business
  • Technology
  • Science
  • Entertainment
  • Sports
  • Health
  • @

Browsing Tag

clinical studies

5 posts
MMedication
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China
Read More

Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Durvalumab Plus Chemotherapy in First-Line Advanced Biliary Tract Cancer in Single-Region Trial Conducted by Akeso in China

  • August 26, 2026
HARMONi-GI1 Conducted in China by Akeso Is First Known Phase III Study in Advanced BTC to Demonstrate OS…
MMedication
Rivaroxaban or Combo Therapy: A Winner for All Ages? - Medscape
Read More

Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape

  • August 24, 2025
Rivaroxaban or Combo Therapy: A Winner for All Ages?  Medscape Rivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary…
MMedication
First New PTSD Drug in Two Decades On the Horizon?
Read More

First New PTSD Drug in Two Decades On the Horizon?

  • July 18, 2025
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…
MMedication
photo of Gamifant
Read More

FDA Approves First Treatment for MAS in Still Disease

  • July 1, 2025
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…
MMedication
More Days, More Resistance: Time to Rethink Antibiotics
Read More

More Days, More Resistance: Time to Rethink Antibiotics

  • July 1, 2025
“One of the most universally accepted beliefs around the world,” said Brad Spellberg, MD, chief medical officer at…
United States
www.europesays.com